Blog

Dr. Melvin's talking about both hip and knee replacement

Read more

Conformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom

BILLERICA, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient’s unique anatomy, today announced that the Orthopaedic Data Evaluation Panel in the United Kingdom (ODEP) awarded the Conformis iTotal CR knee replacement system a “3A” rating.  The 3A rating is based on strong evidence of implant performance over three years, including low revision rates as indicated in the United Kingdom’s National Joint Registry.

Read more

Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR

BILLERICA, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient’s unique anatomy, today announced new data showing that patients treated with the Conformis iTotal CR knee implant experienced a cumulative revision rate of 0.5% at four years compared to a 1.9% cumulative revision rate at the same time-point, among all patients who underwent knee replacement.¹ Results are summarized in a February 2018 report from Beyond Compliance, based on data available in the National Joint Registry (NJR) in the U.K.

Read more

Take intraoperative steps to reduce joint infection risk

With an increasing number of total knee arthroplasty and total hip arthroplasty procedures being performed in the United States, the rate of failure has also increased. In its annual report, the American Joint Replacement Registry listed infection as a leading cause of TKA and THA revisions from 2012 to 2016. Research has also shown failures due to periprosthetic joint infection are expected to increase at an annual rate of between 38,000 cases and 270,000 cases by the year 2030.

Read more

ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%

BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s unique anatomy, today announced the publication of a prospective study in The Journal of Knee Surgery, a peer-reviewed orthopedic journal,on December 14, 2017. The study investigated the ability of the iTotal CR Knee Replacement System restoring coronal plane mechanical axis alignment in a patient’s leg.

Read more